AUG 19, 2026 · PHASE 3 TRIAL
Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers
ClinicalTrials.gov
This is an ongoing Phase 3 trial registration with no results reported; it describes a planned interventional study in a clinically important area but carries no efficacy or safety data yet.
Reported
Estimated enrollment1600
Primary outcome: Safety assessmen…Approximately 6 months
Primary outcome: Recurrent VTE an…Up to approximately 3.5 years